ALLMedicine Acute Urticaria Center
Research & Reviews 143 results
https://doi.org/10.1111/ijd.14950
International Journal of Dermatology References; Falkenhain-López D, Sánchez-Velázquez A et. al.
May 21st, 2020 - SARS-Coronavirus-2 and acute urticaria.|2020|Falkenhain-López D,Sánchez-Velázquez A,López-Valle A,Ortiz-Frutos FJ,|
https://doi.org/10.23822/EurAnnACI.1764-1489.148
European Annals of Allergy and Clinical Immunology; Talarico V, Marseglia GL et. al.
May 6th, 2020 - Introduction.Acute urticaria (AU) in children is a common clinical manifestation responsible for admission to the emergency department (ED). We aimed to analyze the epidemiological characteristics of AU in children and to identify predictors of bo...
https://www.ncbi.nlm.nih.gov/pubmed/32324180
The Medical Letter on Drugs and Therapeutics;
Apr 23rd, 2020 - Intravenous Cetirizine (Quzyttir) for Acute Urticaria.|2020||administration & dosage,adverse effects,pharmacology,administration & dosage,adverse effects,pharmacology,drug therapy,
https://doi.org/10.1016/j.ajem.2020.02.025
The American Journal of Emergency Medicine; Palungwachira P, Vilaisri K et. al.
Feb 18th, 2020 - Acute urticaria is a common dermatological condition in emergency departments (EDs). The main therapy involves controlling pruritus with antihistamines. Although guidelines have promoted the use of corticosteroids in addition to H1 antihistamines,...
https://emedicine.medscape.com/article/1050166-overview
Jan 29th, 2020 - Background Contact urticaria syndrome is a transient wheal and flare reaction (or urticaria) occurring 10-60 minutes at sites of contact of the skin or mucosa to a suspected allergen. It is a form of acute urticaria lasting less than 6 weeks. Alth...
Guidelines 2 results
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.
Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.
https://www.quzyttir.com/
QUZYTTIR™ (cetirizine) injection, for intravenous use INDICATIONS AND USAGE. QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children 6 months of age and older. Limitations of Use: QUZYTTIR is not recommended in pediatric...
Drugs 2 results see all →
Clinicaltrials.gov 155 results
https://doi.org/10.1111/ijd.14950
International Journal of Dermatology References; Falkenhain-López D, Sánchez-Velázquez A et. al.
May 21st, 2020 - SARS-Coronavirus-2 and acute urticaria.|2020|Falkenhain-López D,Sánchez-Velázquez A,López-Valle A,Ortiz-Frutos FJ,|
https://doi.org/10.23822/EurAnnACI.1764-1489.148
European Annals of Allergy and Clinical Immunology; Talarico V, Marseglia GL et. al.
May 6th, 2020 - Introduction.Acute urticaria (AU) in children is a common clinical manifestation responsible for admission to the emergency department (ED). We aimed to analyze the epidemiological characteristics of AU in children and to identify predictors of bo...
https://www.ncbi.nlm.nih.gov/pubmed/32324180
The Medical Letter on Drugs and Therapeutics;
Apr 23rd, 2020 - Intravenous Cetirizine (Quzyttir) for Acute Urticaria.|2020||administration & dosage,adverse effects,pharmacology,administration & dosage,adverse effects,pharmacology,drug therapy,
https://doi.org/10.1016/j.ajem.2020.02.025
The American Journal of Emergency Medicine; Palungwachira P, Vilaisri K et. al.
Feb 18th, 2020 - Acute urticaria is a common dermatological condition in emergency departments (EDs). The main therapy involves controlling pruritus with antihistamines. Although guidelines have promoted the use of corticosteroids in addition to H1 antihistamines,...
https://emedicine.medscape.com/article/1050166-overview
Jan 29th, 2020 - Background Contact urticaria syndrome is a transient wheal and flare reaction (or urticaria) occurring 10-60 minutes at sites of contact of the skin or mucosa to a suspected allergen. It is a form of acute urticaria lasting less than 6 weeks. Alth...
News 5 results
https://www.medscape.com/viewarticle/919911
Oct 14th, 2019 - The US Food and Drug Administration (FDA) has approved cetirizine hydrochloride for intravenous injection (Quzyttir, JDP Therapeutics) for treatment of acute urticaria in adults and children 6 months of age or older. Quzyttir will be available as ...
https://www.medscape.com/viewarticle/894410
Mar 26th, 2018 - Urticaria (hives) is a vascular reaction of the skin marked by the transient appearance of smooth, slightly elevated papules or plaques (wheals) that are erythematous and that are often attended by severe pruritus. Individual lesions resolve witho...
https://www.medscape.com/viewarticle/552643
Mar 5th, 2007 - Position Statements AAEM statements are not to be construed as dictating an exclusive course of action nor are they intended to replace the medical judgment of healthcare professionals. The unique circumstances of individual patients and environme...
https://www.medscape.com/viewarticle/777624
Abstract and Introduction Abstract Urticaria and angioedema are common allergic manifestations and some forms of this disorder may be increasing in both prevalence and severity due to changes in medications, environment and other unknown factors. ...
https://www.quzyttir.com/
QUZYTTIR™ (cetirizine) injection, for intravenous use INDICATIONS AND USAGE. QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children 6 months of age and older. Limitations of Use: QUZYTTIR is not recommended in pediatric...
